Company: RGBP
Filing Date: 2025-09-08
Form Type: 253G1
Source: 0001641172-25-026822
Chunk: 91

Company: Regen BioPharma Inc
Filing Date: 2025-09-08
Form: 253G1
Chunk 91
---
. No public market exists for any of the securities of Zander Therapeutics, Inc. The Company owns 7.9% of the total shares of Zander Therapeutics, Inc.

Investments consisted of the following:

SCHEDULE OF INVESTMENT

|                                                         |     |   |         As of 
 March 31,2025 |     |   |         As of 
 September 30, 
          2024 |
|:--------------------------------------------------------|:----|:--|--------------:|:----|:--|--------------:|
| 470,588 Common Shares of Zander Therapeutics, Inc.      |     | $ |         6,495 |     | $ |         6,495 |
| 725,000 Series M Preferred of Zander Therapeutics, Inc. |     |   |        11,238 |     |   |        11,238 |
| Investments, net                                        |     | $ |        17,733 |     | $ |        17,333 |

Common Shares of Zander Therapeutics, Inc.

On June 11, 2018, Regen Biopharma, Inc. was paid a property dividend consisting of 470,588 of the common shares of Zander Therapeutics, Inc.

| Basis |        |     | Fair Value |       |     | Total Unrealized Gains/(Loss) |         |   |
|:------|-------:|:----|:-----------|------:|:----|:------------------------------|:--------|:--|
| $     | 87,608 |     | $          | 6,495 |     | $                             | (81,112 | ) |

Series M Preferred of Zander Therapeutics, Inc. On November 29, 2018, the Company accepted 725,000 shares of the Series M Preferred stock of Zander Therapeutics, Inc. in satisfaction of prepaid rent and accrued interest owed to the Company collectively amounting to $13,124.

| Basis |         |     | Fair Value |        |     | Total Unrealized Gains/(Loss) |          |   |
|:------|--------:|:----|:-----------|-------:|:----|:------------------------------|:---------|:--|
| $     | 134,971 |     | $          | 11,238 |     | $                             | (123,733 | ) |

| 75 |

On March 31, 2025 and September 30